The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 21, 2020

Filed:

Apr. 29, 2011
Applicants:

Yu-shen Hsu, Xizhi, TW;

I-ling Kou, Xizhi, TW;

Kuo-chan Hung, Xizhi, TW;

Yuan-hsin LU, Xizhi, TW;

Ta-tung Yuan, Xizhi, TW;

Inventors:

Yu-Shen Hsu, Xizhi, TW;

I-Ling Kou, Xizhi, TW;

Kuo-Chan Hung, Xizhi, TW;

Yuan-Hsin Lu, Xizhi, TW;

Ta-Tung Yuan, Xizhi, TW;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/09 (2006.01); A61K 39/102 (2006.01); A61K 47/64 (2017.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/092 (2013.01); A61K 39/102 (2013.01); A61K 47/646 (2017.08); A61K 47/6415 (2017.08); A61K 2039/6037 (2013.01);
Abstract

A detoxified recombinantheat-labile enterotoxin mutant, LTS61K, is employed as a carrier protein to conjugate polysaccharide. The LTS61K contains a mutated mature sub-unit A (LTA) that includes lysine at amino acid position 61 and a wild-type mature sub-unit B (LTB). Various types of bacterial capsular polysaccharide antigens were chemically conjugated with the LTS61K protein by a reductive amination reaction. The conjugated polysaccharide-LTS61K products were physically, chemically and biochemically identified as soluble form. Rabbits were immunized intramuscularly to determine the immunogenicity of conjugated vaccines by ELISA to detect anti-polysaccharide antigen IgG titers and serum bactericidal assay thereby determining the functional activity of the antibodies. Study results show that conjugated polysaccharide-LTS61K vaccines induce higher polysaccharide-specific IgG titers and greater bactericidal activity in sera than that of polysaccharide alone or polysaccharide mixed with LTS61K. The presence of anti-LTS61K serum IgG antibody alleviates travel diarrhea caused by(ETEC enterotoxigenic).


Find Patent Forward Citations

Loading…